I am a member of the ROSCO Trial Management Group and Surgical Lead for this important study looking to improve the use of chemotherapy prior to surgery in women with breast cancer. The TMG oversees the delivery of the trial, and I provide advice and expertise to the study regarding all aspects of the surgical treatment of enrolled patients. ROSCO will recruit over 1000 patients in a 4 year period, and will report in 2024.